Tae Bo Sim

USPTO Granted Patents = 21 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 63(Granted Patents)

Location History:

Daegu, KR (2014)
Seoul, KR (2000 - 2022)

Company Filing History:

18 out of 2,168

Korea Institute of Science and Technology

patents

2 out of 15,475

University of California

patents

2 out of 63

Hanmi Science Co., Ltd.

patents

4. 1 out of 624

Korea Research Institute of Chemical Technology

patents

5. 1 out of 321

Korea Research Institute of Bioscience and Biotechnology

patents

6. 1 out of 146

Hanmi Pharm. Co., Ltd.

patents

7. 1 out of 8

Daegu-gyeongbuk Medical Innovation Foundation

patents

8. 1 out of 1,112

Industry-University Cooperation Foundation Hanyang University

patents

9. 1 out of 54

Catholic University Industry Academic Cooperation Foundation

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466812 - Pyridinyltriazine derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, ameliorating, or treating cancer comprising same (2025-11-11),

2. 11530221 - Pyrimido[4,5-d]pyrimidin-2-one derivatives as protein kinase inhibitors (2022-12-20),

3. 10683282 - Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activities (2020-06-16),

4. 10494346 - Substituted pyrimidine-4-carboxylic acids having anticancer activity (2019-12-03),

5. 10442796 - 2,3,5-substituted thiophene compound as protein kinase inhibitor (2019-10-15),

6. 10155767 - Therapeutic agent of acute myeloid leukemia containing 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-D]pyrimidine-2(1H)-one derivatives (2018-12-18),

7. 10130631 - CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds (2018-11-20),

8. 10112954 - Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase (2018-10-30),

9. 10059717 - Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitors (2018-08-28),

10. 10040803 - 4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors (2018-08-07),

11. 9586936 - Heteroarylamine derivatives as protein kinase inhibitors (2017-03-07),

12. 9422307 - 2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors (2016-08-23),

13. 8999973 - Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases (2015-04-07),

14. 8871950 - Process for preparing (+)-polyoxamic acid (2014-10-28),

15. 8765749 - 1,6-disubstituted indole compounds as protein kinase inhibitors (2014-07-01),

Title: The Innovative Journey of Inventor Tae Bo Sim

Introduction: Tae Bo Sim, a visionary inventor hailing from Seoul, South Korea, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Tae Bo Sim holds several patents in various fields, including technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Tae Bo Sim has been recognized for his innovative spirit and problem-solving abilities. His inventions have not only improved the quality of life for many but have also set new standards in the industry.

Collaborations: Tae Bo Sim has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that have made a positive impact on society.

Conclusion: In conclusion, Tae Bo Sim stands as a testament to the power of innovation and creativity. His relentless pursuit of excellence and passion for inventing have solidified his position as a respected figure in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.